Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy GBS stock | $3.01

Learn how to easily invest in GBS stock.

-$0.08 (-2.41%)

GBS Inc is a medical devices business based in the US. GBS shares (GBS) are listed on the NASDAQ and all prices are listed in US Dollars. GBS employs 7 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in GBS

  1. Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – GBS – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

GBS stock price (NASDAQ: GBS)

Use our graph to track the performance of GBS stocks over time.

GBS shares at a glance

Information last updated 2021-07-28.
Latest market close$3.01
52-week range$2.62 - $14.24
50-day moving average $3.77
200-day moving average $5.22
Wall St. target priceN/A
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) N/A

Buy GBS shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Asset types Option trade fee Annual fee Signup bonus
Sofi Invest
Stocks, ETFs, Cryptocurrency
Get one free stock worth up to $1,000
Open an account
A free way to invest in stocks, ETFs and crypto.
Stocks, Options, ETFs
Get one free stock valued between $3.00 and $300 when you open an account, one more with a deposit
Open an account
Margin financing rates start at 3.99%. No monthly subscription fees for margin.
Stocks, ETFs
$0 per month
Download and sign up with; approved accounts receive a free stock slice worth up to $70, selected from 9 popular stocks.
Open an account
Commission-free trading in stocks and ETFs with a social networking twist.
J.P. Morgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0 + $0.65/contract
Stocks, Options, ETFs
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Stocks, Options, ETFs
$0 per year
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy GBS stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

GBS price performance over time

Historical closes compared with the close of $3.01 from 2021-05-28

1 week (2021-07-21) N/A
1 month (2021-07-01) -18.21%
3 months (2021-04-30) -23.80%
6 months (2021-01-28) N/A
1 year (2020-07-28) N/A
2 years (2019-07-28) N/A
3 years (2018-07-28) N/A
5 years (2016-07-28) N/A

GBS financials

Revenue TTM $441,754
Gross profit TTM $188,744
Return on assets TTM -30.7%
Return on equity TTM -133.02%
Profit margin 0%
Book value $1.34
Market capitalisation $40.9 million

TTM: trailing 12 months

Shorting GBS shares

There are currently 360,285 GBS shares held short by investors – that's known as GBS's "short interest". This figure is 54.6% down from 793,858 last month.

There are a few different ways that this level of interest in shorting GBS shares can be evaluated.

GBS's "short interest ratio" (SIR)

GBS's "short interest ratio" (SIR) is the quantity of GBS shares currently shorted divided by the average quantity of GBS shares traded daily (recently around 923807.69230769). GBS's SIR currently stands at 0.39. In other words for every 100,000 GBS shares traded daily on the market, roughly 390 shares are currently held short.

To gain some more context, you can compare GBS's short interest ratio against those of similar companies.

However GBS's short interest can also be evaluated against the total number of GBS shares, or, against the total number of tradable GBS shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case GBS's short interest could be expressed as 0.03% of the outstanding shares (for every 100,000 GBS shares in existence, roughly 30 shares are currently held short) or 0.0626% of the tradable shares (for every 100,000 tradable GBS shares, roughly 63 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against GBS.

Find out more about how you can short GBS stock.

GBS share dividends

We're not expecting GBS to pay a dividend over the next 12 months.

You may also wish to consider:

Have GBS's shares ever split?

GBS's shares were split on a 2000:1 basis on 9 April 2017. So if you had owned 1 share the day before before the split, the next day you'd have owned 2000 shares. This wouldn't directly have changed the overall worth of your GBS shares – just the quantity. However, indirectly, the new 100% lower share price could have impacted the market appetite for GBS shares which in turn could have impacted GBS's share price.

GBS overview

GBS Inc. operates as a biosensor diagnostic technology company. Its principal product is Saliva Glucose Biosensor, a saliva glucose monitoring system for diabetes management. The company also focuses on developing other diagnostic tests in the areas of biochemistry, tumor markers, immunology, hormones, and other biomarkers. It has a research agreement with Johns Hopkins Bloomberg School of Public Health for the development of saliva-based diagnostic tests. GBS Inc. was formerly known as Glucose Biosensor Systems (Greater China) Holdings, Inc.

Frequently asked questions

What percentage of GBS is owned by insiders or institutions?
Currently 46.905% of GBS shares are held by insiders and 0.597% by institutions.
How many people work for GBS?
Latest data suggests 7 work at GBS.
When does the fiscal year end for GBS?
GBS's fiscal year ends in June.
Where is GBS based?
GBS's address is: 708 3rd Avenue, New York, NY, United States, 10017

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site